why choose us

First received: January 30, 2023

Clinical Trial: Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Prostatic Neoplasms, Castration-Resistant

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-Label, Dose-Finding Study of TVB-2640 Administered in Combination With Enzalutamide (Xtandi) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Brief Summary: The purpose of this study is to determine what effects (good and bad) Enzalutamide and TVB-2640 have in the treatment of prostate cancer whose prostate cancer has spread to other parts of their body and that has not gotten better with previous treatment.This study is a Phase I clinical trial.Phase I clinical trials test the side effects of an investigational drug or an investigational combination with another drug."Investigational" means that the drug is still being studied and research doctors are…

Read more